1. Home
  2. SCHL vs TBPH Comparison

SCHL vs TBPH Comparison

Compare SCHL & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholastic Corporation

SCHL

Scholastic Corporation

HOLD

Current Price

$40.25

Market Cap

842.4M

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.05

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCHL
TBPH
Founded
1920
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Books
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
842.4M
824.9M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
SCHL
TBPH
Price
$40.25
$16.05
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
$40.00
$18.40
AVG Volume (30 Days)
262.4K
289.3K
Earning Date
03-19-2026
05-04-2026
Dividend Yield
1.99%
N/A
EPS Growth
N/A
279.13
EPS
1.87
N/A
Revenue
$1,487,100,000.00
$15,386,000.00
Revenue This Year
$1.88
$8.46
Revenue Next Year
$4.05
N/A
P/E Ratio
$21.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.81
$9.98
52 Week High
$43.39
$21.03

Technical Indicators

Market Signals
Indicator
SCHL
TBPH
Relative Strength Index (RSI) 52.51 40.51
Support Level $37.84 $13.41
Resistance Level $43.39 $17.21
Average True Range (ATR) 1.23 0.34
MACD 0.03 -0.06
Stochastic Oscillator 68.36 4.84

Price Performance

Historical Comparison
SCHL
TBPH

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: